Chi-st Vincent Infirmary | |
Two St Vincent Circle, Little Rock, Arkansas 72205 | |
(501) 552-3000 | |
Name | Chi-st Vincent Infirmary |
---|---|
Type | Acute Care Hospital |
Location | Two St Vincent Circle, Little Rock, Arkansas |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 040007 |
NPI Number | 1346630589 |
Organization Name | CHG HOSPITAL LITTLE ROCK, LLC |
Doing Business As | CORNERSTONE SPECIALTY HOSPITALS LITTLE ROCK |
Address | 2 Saint Vincent Cir, 6th Floor, Little Rock, AR 72205 |
Hospital Type | Long Term Care Hospital |
Phone Number | 501-265-0600 |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
NPI Number | 1417957200 |
Organization Name | SELECT SPECIALTY HOSPITAL - LITTLE ROCK/BMC INC |
Address | 9601 Interstate 630, Exit 7, 10th Floor, Little Rock, AR 72205 |
Hospital Type | Long Term Care Hospital |
Phone Number | 501-202-1095 |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
NPI Number | 1578563326 |
Organization Name | SELECT SPECIALTY HOSPITAL - LITTLE ROCK INC |
Address | 2 Saint Vincent Cir, 6th Fl, Little Rock, AR 72205 |
Hospital Type | Long Term Care Hospital |
Phone Number | 501-552-8321 |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
NPI Number | 1629011002 |
Organization Name | ST. VINCENT INFIRMARY MEDICAL CENTER |
Doing Business As | ST. VINCENT MEDICAL CENTER - NORTH |
Address | 2215 Wildwood Ave, Sherwood, AR 72120 |
Hospital Type | General Acute Care Hospital |
Phone Number | 501-552-3150 |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
NPI Number | 1780684431 |
Organization Name | ST VINCENT INFIRMARY MEDICAL CENTER |
Doing Business As | ST. VINCENT HEALTH SYSTEM |
Address | 2 Saint Vincent Cir, Little Rock, AR 72205 |
Hospital Type | General Acute Care Hospital |
Phone Number | 501-552-3150 |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
NPI Number | 1912964081 |
Organization Name | ST VINCENT INFIRMARY MEDICAL CENTER |
Doing Business As | ST VINCENT HEALTH SYSTEMS |
Address | 2 Saint Vincent Cir, Little Rock, AR 72205 |
Hospital Type | General Acute Care Hospital |
Phone Number | 501-552-3999 |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
British women living with a partner are more than twice as likely to lack interest in sex compared to men living with a partner, according to a new study published in the BMJ Open.
Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.
During a hearing of the House Oversight And Government Reform Committee, Republicans tagged this provision as an insurance industry bail-out despite Congressional Budget Office projections cited by Democrats that it ultimately will collect billions of dollars from insurers rather than paying them money.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 5 days ago
Chi-st Vincent Infirmary Acute Care Hospital Location: Two St Vincent Circle, Little Rock, Arkansas 72205 Phone: (501) 552-3000 | |
Uams Medical Center Acute Care Hospital Location: 4301 West Markham Street Mail Slot 612, Little Rock, Arkansas 72205 Phone: (501) 686-5000 | |
Baptist Health Medical Center-little Rock Acute Care Hospital Location: 9601 Interstate, Little Rock, Arkansas 72205 Phone: (501) 202-2000 | |
Arkansas Heart Hospital, Llc Acute Care Hospital Location: 1701 S Shackleford Road, Little Rock, Arkansas 72211 Phone: (501) 219-7000 | |
Arkansas Childrens Hospital Childrens Hospital Location: 1 Children's Way, Slot 301, Little Rock, Arkansas 72202 Phone: (501) 364-1100 | |
Arkansas State Hospital Psychiatric Hospital Location: 305 S Palm Street, Little Rock, Arkansas 72205 Phone: (501) 686-9000 |